Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?

被引:22
作者
Izzedine, Hassane [1 ]
Thibault, Vincent [2 ]
Valantin, Marc Antoine [3 ]
Peytavin, Gilles [4 ]
Schneider, Luminita [3 ]
Benhamou, Yves [5 ]
机构
[1] Grp Hosp Pitie Salpetriere, Dept Nephrol, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Dept Virol Lab, F-75634 Paris, France
[3] Grp Hosp Pitie Salpetriere, Dept Infect Dis, F-75634 Paris, France
[4] Hop Bichat Claude Bernard, Dept Pharmacol, F-75877 Paris 18, France
[5] Grp Hosp Pitie Salpetriere, Dept Hepatol, F-75634 Paris, France
关键词
PHARMACOKINETICS; CIDOFOVIR; ADEFOVIR; VIRUS;
D O I
10.1097/QAD.0b013e3283313f54
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1078 / 1079
页数:2
相关论文
共 4 条
[1]   Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].
Benhamou, Y ;
Bochet, M ;
Thibault, V ;
Calvez, V ;
Fievet, MH ;
Vig, P ;
Gibbs, CS ;
Brosgart, C ;
Fry, J ;
Namini, H ;
Katiama, C ;
Poynard, T .
LANCET, 2001, 358 (9283) :718-723
[2]   Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs [J].
Cundy, KC ;
Sueoka, C ;
Lynch, GR ;
Griffin, L ;
Lee, WA ;
Shaw, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :687-690
[3]  
Lacy SA, 1998, TOXICOL SCI, V44, P97, DOI 10.1006/toxs.1998.2481
[4]   Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2) [J].
Uwai, Yuichi ;
Ida, Hiroki ;
Tsuji, Yoshie ;
Katsura, Toshiya ;
Inui, Ken-ichi .
PHARMACEUTICAL RESEARCH, 2007, 24 (04) :811-815